SPX4,274.04-31.16 -0.72%
DIA340.20-1.54 -0.45%
IXIC12,938.12-164.43 -1.25%

Recap: NovoCure Q2 Earnings

  NovoCure (NASDAQ:NVCR) reported its Q2 earnings results on Thursday, July 28, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

Benzinga · 07/28/2022 07:35

 

NovoCure (NASDAQ:NVCR) reported its Q2 earnings results on Thursday, July 28, 2022 at 06:00 AM.

Here's what investors need to know about the announcement.

Earnings

NovoCure missed estimated earnings by 53.33%, reporting an EPS of $-0.23 versus an estimate of $-0.15.

Revenue was up $7.35 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.14 which was followed by a 0.78% drop in the share price the next day.

Here's a look at NovoCure's past performance:

 

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.18 -0.10 -0.07 0.01
EPS Actual -0.04 -0.25 -0.13 -0.14
Revenue Estimate 134.08M 135.42M 141.76M 141.89M
Revenue Actual 137.55M 133.21M 133.61M 133.52M

To track all earnings releases for NovoCure VISIT THEIR EARNINGS CALENDAR HERE.

This article was generated by Benzinga's automated content engine and reviewed by an editor.